Citation

Trakoli A. Breathe 2021; 17(1): 1-8.

Copyright

(Copyright © 2021)

DOI

10.1183/20734735.0004-2021

PMID

unavailable

Abstract

Treatment burden can adversely affect patient functioning and wellbeing, including their ability work. Workers with multimorbidity, such as ageing, are disproportionately affected and their number is set to rise as the workforce ages. Complex treatment regimens and their sequalae can be a barrier to a successful return to work or even incompatible with work demands. Enlightened employers will seek to accommodate the burden of treatment by implementing reasonable adjustments. However, where the employer is unable or unwilling to accommodate such adjustments, the result may be loss of employment, with often devastating consequences to the worker's physical and emotional health and wellbeing. Collaborative action in three key settings: the healthcare system, the workplace and the state can help reduce barriers, thereby enabling working-age people with chronic health conditions or disabilities remain in, and benefit from, employment. © 2021, European Respiratory Society. All rights reserved.

Language: en

Keywords

human; mental health; suicide; Review; exercise; workload; depression; anxiety; diet; wellbeing; antihypertensive agent; neuroleptic agent; sedation; tricyclic antidepressant agent; vaccination; anticoagulant agent; employment; social status; interferon; health care personnel; beta adrenergic receptor blocking agent; self esteem; insulin; health care system; immunosuppressive treatment; drug therapy; gentamicin; blood glucose monitoring; self monitoring; diuretic agent; work capacity; chloroquine; job adaptation; lifestyle modification; scientist; shift worker; medication compliance; return to work; clinical outcome; continuous positive airway pressure; point of care testing; pulmonary rehabilitation